Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.26M P/E - EPS this Y 43.20% Ern Qtrly Grth -
Income -13.32M Forward P/E -0.47 EPS next Y 0.80% 50D Avg Chg -15.00%
Sales 4.91M PEG - EPS past 5Y - 200D Avg Chg -49.00%
Dividend N/A Price/Book 2.20 EPS next 5Y - 52W High Chg -86.00%
Recommedations 2.00 Quick Ratio 0.80 Shares Outstanding 4.35M 52W Low Chg 24.00%
Insider Own 1.45% ROA -47.23% Shares Float 4.21M Beta 0.56
Inst Own 3.27% ROE -522.50% Shares Shorted/Prior 46.50K/32.23K Price 2.44
Gross Margin -97.23% Profit Margin -271.04% Avg. Volume 32,904 Target Price 28.20
Oper. Margin -293.98% Earnings Date Apr 26 Volume 5,619 Change -2.40%
About PLUS THERAPEUTICS, Inc.

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer. Its lead radiotherapeutic drug candidate is rhenium (186Re) obisbemeda, a patented radiotherapy that targets central nervous system cancers and other cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. The company also develops Rhenium-188 NanoLiposome Biodegradable Alginate Microsphere that is designed to treat various solid organ cancers comprising primary and secondary liver cancers by intra-arterial injection. It has license agreements with NanoTx, Corp. and The University of Texas Health Science Center at San Antonio. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

PLUS THERAPEUTICS, Inc. News
04/22/24 Micro-Cap Brain Cancer Focused Plus Therapeutics Poised To Receive $3M From US Department of Defense
04/22/24 Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense
04/09/24 Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plusโ€™ Management Team
03/27/24 Plus Therapeutics to Present at the National Comprehensive Cancer Network Annual Conference
03/25/24 Plus Therapeutics Announces Validation & Clinical Implementation of CSF-01 Leptomeningeal Cancer Cell Diagnostic
03/11/24 Plus Therapeutics Completes Dosing in Cohort 5 of ReSPECT-LM Phase 1 Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases
03/07/24 Plus Therapeutics, Inc. (NASDAQ:PSTV) Q4 2023 Earnings Call Transcript
03/07/24 Plus Therapeutics Full Year 2023 Earnings: Beats Expectations
03/06/24 Q4 2023 Plus Therapeutics Inc Earnings Call
03/05/24 Plus Therapeutics (PSTV) Reports Q4 Loss, Tops Revenue Estimates
03/05/24 Plus Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
02/27/24 Plus Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on March 5, 2024
12/18/23 Plus Updates Financial and Cash Guidance for 2024
12/12/23 Plus Therapeutics Partners With K2bio for Development of Novel Tests for Cerebrospinal Fluid (CSF) Tumor Cell and Molecular Biomarker Analyses
11/29/23 Plus Therapeutics to Present at the 5th Targeted Radiopharmaceuticals Summit Europe
11/20/23 Plus Therapeutics Reports New Interim ReSPECT-GBM Phase 2 Trial Data at the Society for NeuroOncology Annual Meeting and will Host Key Opinion Leader Webinar
11/15/23 Plus Therapeutics to Host Virtual KOL Event on New Phase 2 ReSPECT-GBM Data in Recurrent Glioblastoma Presented at the Society for NeuroOncology (SNO) Conference on Monday, November 20, 2023
11/13/23 Thinking about buying stock in Tivic Health Systems, Tigo Energy, TAT Technologies, Plus Therapeutics, or Acumen Pharmaceuticals?
11/03/23 Plus Therapeutics Granted U.S. FDA Orphan Drug Designation to Rhenium (186Re) Obisbemeda for the Treatment of Breast Cancer with Leptomeningeal Metastases
11/01/23 Plus Therapeutics, Inc. (NASDAQ:PSTV) Q3 2023 Earnings Call Transcript
PSTV Chatroom

User Image yenkins Posted - 24 minutes ago

@TheRipple add $PSTV

User Image vaselineguy Posted - 9 hours ago

$PSTV but but momo said...

User Image Terry_CA3 Posted - 1 day ago

$PSTV why arenโ€™t CEOs saying anything about the stock prices. Or are they complicit? https://x.com/kshaughnessy2/status/1783453825342259341?s=46&t=3O-WutLip8DhbYBC3iYf6A

User Image pa600a Posted - 1 day ago

$PSTV Department of Defense just donated .70 cents per share to the bottom line.

User Image ADAMSFBAYINVESTOR Posted - 1 day ago

$SLS you're 100% right about it. I'm very tired and hoping that whoever short all of my biotech stocks like $SLS $PSTV $BLRX got cancer but can't their treatment.

User Image stockregion Posted - 3 days ago

Breakthrough in Pediatric Brain Cancer Research: Plus Therapeutics Secures $3 Million DoD Award. In an unprecedented move that signals a new era for cancer treatment, Plus Therapeutics, Inc., a trailblazer in the development of targeted radiotherapeutics, has been awarded a $3 million grant by the Department of Defense (DoD) through its Congressionally Directed Medical Research Programs (CDMRP). This substantial funding, set to kick off in Q3 2024, is earmarked for the expansion of clinical trials focused on pediatric brain cancer, offering a glimmer of hope for countless families and medical professionals grappling with this devastating diagnosis. $PSTV https://stockregion.app/p/therapeutics-company-secures-3m-department

User Image vaselineguy Posted - 3 days ago

$PSTV where is the retard Momo the hungryearner the grid player? He told me see a you above 20 before last rs (300 now) his beloved lmao

User Image vaselineguy Posted - 3 days ago

$PSTV @plustherapeutics lmao market doesn't believe your shix.

User Image kwintz Posted - 3 days ago

$pstv if a 3MM grant gets them under 1.6/sh. maybe a $10MM grant will get them under $1/sh. wtf

User Image Bilwilly Posted - 4 days ago

$PSTV letโ€™s go!๐Ÿ’ช๐Ÿ‘๐Ÿ‘‰

User Image shebo Posted - 4 days ago

$PSTV 3 million government contract

User Image DonCorleone77 Posted - 4 days ago

$PSTV Plus Therapeutics receives $3M award recommendation from U.S. DOD Plus Therapeutics announced it has been selected for funding by the Department of Defense office of the Congressionally Directed Medical Research Programs. The award is expected to commence in Q3 2024 and will support the planned expansion of the Company's clinical trial for pediatric brain cancer. "This recent award further extends our current cash runway in the second half of 2025, while supporting the 2024 expansion of our clinical development activities," said Marc H. Hedrick, M.D., President & CEO of Plus Therapeutics. "In 2023, the Company applied for approximately $7 million in grant funding, and we plan to file for more than $10 million in funding in 2024."

User Image PLATINUM_TRADES Posted - 4 days ago

$PSTV break $1.75 for a shot at $2.00 here ๐ŸฅŠ๐ŸฅŠ

User Image Stock_Titan Posted - 4 days ago

$PSTV Plus Therapeutics Receives $3 Million Award Recommendation from the United States Department of Defense https://www.stocktitan.net/news/PSTV/plus-therapeutics-receives-3-million-award-recommendation-from-the-ktbspk0n8a62.html

User Image Ruenner_G Posted - 6 days ago

$PSTV Don't touch until they actually have an fda approved PBC ind. If fda approves investigation in 186rnl for children, that's how you know they're going to be bought in to approve for 186rnl with adults late stage. But do not touch until then, no indication that will happen. They are YEARS late on it. Xbi should bounce back any day but pstv may get stuck finding < 1 again.

User Image vaselineguy Posted - 1 week ago

$PSTV @plustherapeutics any good news tomorrow? A new powerpoint?

User Image TheRipple Posted - 1 week ago

$PSTV $JAGX ๐Ÿ‘€

User Image vaselineguy Posted - 1 week ago

$PSTV @plustherapeutics you will cure cancer... Lmao.

User Image TheRipple Posted - 1 week ago

$JAGX $PSTV Nice chatting

User Image DJWon Posted - 1 week ago

$PSTV I saw that little swap ๐Ÿง

User Image vaselineguy Posted - 1 week ago

$PSTV @plustherapeutics great performance market green you are red, market red you are red. Congrats to the CEO no matters what market do you always are stinky.

User Image ADAMSFBAYINVESTOR Posted - 2 weeks ago

$SLS I'm hoping and praying days and nights that $SLS can pop big this month, hopefully 10X at least so I can buy a ton of $PSTV and $BLRX to average down. I've been long in these 3 for almost 4 years. Good luck to all!

User Image cluvin Posted - 2 weeks ago

$PSTV big order coming in new news 100% before end of day get yours fast, spread the word $AKAN make money

User Image alejajcucha Posted - 2 weeks ago

$PSTV ๐Ÿš€๐Ÿš€๐Ÿš€ โ€ฆ. Plus Therapeutics (PSTV โ€“ Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Justin Walsh from JonesTrading maintained a Buy rating on the stock and has a $32.00 price targetโ€ฆ.. Buy Rating Affirmed for Plus Therapeutics Amidst Clinical Advancements and Industry Tailwinds | Markets Insider https://www.tipranks.com/news/blurbs/buy-rating-affirmed-for-plus-therapeutics-amidst-clinical-advancements-and-industry-tailwinds?utm_source=markets.businessinsider.com&utm_medium=referral

User Image plustherapeutics Posted - 2 weeks ago

$PSTV #ICYMI : "Plus Therapeutics (PSTV), the Healthcare sector company, was revisited by a Wall Street analyst...Analyst Justin Walsh from JonesTrading maintained a Buy rating on the stock and has a $32.00 price target." http://BusinessInsider.com article: https://bit.ly/3U5ePn7

User Image vaselineguy Posted - 2 weeks ago

$PSTV lmao @plustherapeutics 113 shares traded today pathetic

User Image plustherapeutics Posted - 2 weeks ago

$PSTV We would like to officially welcome Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. to the Plus Therapeutics Management Team! โ€œAs we prepare for the future, Plus is substantially strengthening its management in key areas such as cancer biology, neuro-oncologic clinical development, and central nervous system biomarker development,โ€ said Marc Hedrick, M.D., M.B.A. โ€œI have worked closely with both Dr. Brenner and Dr. Blouw for some time now, and they are important new additions for our future. Their positive impact will be felt immediately.โ€ Press Release: https://bit.ly/PSTV_PR

User Image Stock_Titan Posted - 2 weeks ago

$PSTV Neuro-Oncologist Andrew Brenner, M.D., Ph.D. and Barbara Blouw, Ph.D. Join Plusโ€™ Management Team https://www.stocktitan.net/news/PSTV/neuro-oncologist-andrew-brenner-m-d-ph-d-and-barbara-blouw-ph-d-join-6kmzciek54x8.html

User Image magic2007 Posted - 2 weeks ago

$PSTV $JAGX I have invested in both over the years hoping to help out mankind with financial support. I am not a scientist so this is my way of trying to make the lives of those who have these illnesses better To see clowns trashing these stock make me wonder what they would do if they got cancer. I will stay the coarse and stay strong. For all the longs I thank you. Stay

User Image vaselineguy Posted - 2 weeks ago

$PSTV @plustherapeutics lmao another poster pathetic company

Analyst Ratings
HC Wainwright & Co. Buy Aug 15, 23
HC Wainwright & Co. Buy Aug 14, 23
HC Wainwright & Co. Buy Jun 30, 23
Maxim Group Buy May 3, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
HEDRICK MARC H Chief Executive Offi.. Chief Executive Officer Nov 20 Sell 1.9597 2,068 4,053 170 12/15/23
Lenk Robert P Director Director Nov 15 Buy 1.86 2,000 3,720 25,160 11/17/23
Lenk Robert P Director Director Nov 08 Buy 1.62 9,199 14,902 17,160 11/13/23
Lenk Robert P Director Director Nov 06 Buy 1.57 7,395 11,610 7,961 11/08/23
Clowes Howard Director Director Sep 13 Buy 1.4331 6,993 10,022 11,693 09/15/23
Petersen Greg Director Director Sep 11 Buy 1.7031 20,000 34,062 24,166 09/12/23
Clowes Howard Director Director Jun 06 Buy 3.98 1,000 3,980 4,700 06/08/23
Clowes Howard Director Director May 03 Buy 3.6406 2,500 9,102 3,700 05/04/23
Hawkins Richard J Director Director Mar 03 Buy 1000.00 1 1,000 1 03/06/23
HEDRICK MARC H Chief Executive Offi.. Chief Executive Officer Jun 15 Buy 0.648 5,000 3,240 33,580 06/16/22
Clowes Howard Director Director Jun 02 Buy 0.5726 15,000 8,589 18,000 06/06/22
HEDRICK MARC H Chief Executive Offi.. Chief Executive Officer Apr 27 Buy 0.6841 2,500 1,710 28,580 04/28/22
Sims Andrew John Hugh MacIntyr... Chief Financial Offi.. Chief Financial Officer Apr 26 Buy 0.672 3,000 2,016 12,230 04/27/22
HEDRICK MARC H Chief Executive Offi.. Chief Executive Officer Apr 26 Buy 0.69 5,000 3,450 26,080 04/27/22
Sims Andrew John Hugh MacIntyr... Chief Financial Offi.. Chief Financial Officer Mar 01 Buy 1.0999 2,000 2,200 9,230 03/03/22
Sims Andrew John Hugh MacIntyr... Chief Financial Offi.. Chief Financial Officer Jul 29 Buy 1.98 4,230 8,375 4,230 07/29/21